because of the magnitude of the problem of nsaid-induced gastric ulceration and the expense of treatments and hospitalizations , the use of misoprostol in preventing these ulcers should be clinically beneficial , and may contribute to significant cost savings in the hospital and other managed-care settings .
C0038358
gastric ulceration
C0085174
misoprostol